ODDB.org: Open Drug Database

Novo Nordisk Pharma AG - Insulin NovoNordisk NovoRapid, Injektionslösung

Swissmedic Registration	55045	Sequence	01
Product name	Insulin NovoNordisk NovoRapid	Description	Injektionslösung
ATC-Classification	A10AB05	ATC-Description	Insulin Aspart
Introduction of Sequence	15.06.1999

Composition

insulinum aspartum 100 U. Corresp. 3.5 mg, glycerolum, phenolum, metacresolum, zinci chloridum, natrii chloridum, dinatrii phosphas dihydricus, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.9 mg.

Packungsbestandteile

Galenic Form

Injection solution

Excipiens

Active Agent	Dose
Insulin Aspart	100 U

BAG: Active Agent	Dose
Insulin Aspart	100 U

Inactive agents
Acidum Hydrochloridum ad Ph
Disodium Phosphate Dihydrate
Glycerol
Metacresol
Sodium Chloride
Natrii Hydroxidum ad Ph
Phenol
Zinc Chlorideate

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
002	10 ml	19.77	37.90	B	SL	Yes

2024	©ywesee GmbH